Audentes Therapeutics, Inc.'s Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:33PM EST
Who is Audentes Therapeutics, Inc.?
Audentes Therapeutics, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Taysha Gene Therapies, Inc..
SEC CIK
Audentes Therapeutics, Inc.'s CIK is 0001628738
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Taysha Gene Therapies, Inc. (TSHA) Snapshot price: $2.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||